Why the study?
Does head-up tilt testing distinguish neurocardiogenic vasodepressor syncope from pacemaker syndrome in patients with syncope after pacemaker implantation?
Does head-up tilt testing distinguish neurocardiogenic vasodepressor syncope from pacemaker syndrome in patients with syncope after pacemaker implantation?
Head-up tilt testing is a useful diagnostic tool to differentiate neurocardiogenic vasodepressor syncope from pacemaker syndrome in patients presenting with syncope after pacemaker implantation.
No takes yet. Share an insight, caveat, or question.
Tilt testing may distinguish neurocardiogenic syncope from pacemaker syndrome post-implant; hypothesis-generating and requires prospective validation.
Abe et al. (1996) studied this question.